NCT01452009View on ClinicalTrials.gov

Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost Ophthalmic Solution, 0.004% (New Formulation)

Travoprost Ophthalmic Solution, 0.004% given one drop once daily

DRUG

TRAVATAN®

TRAVATAN® administered one drop once daily

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY